Scientific Review

Saving money in the European healthcare systems with biosimilars

Published in: Volume 7 / Year 2013 / Issue 1
Page: 15-21

Abstract: Introduction:The use of biotechnological manufactured drugs, or biologicals, has increased massively over the past few years. Used especially in the treatment of cancer and other severe diseases, biologicals incur… Read More »

Treatment of early breast cancer: an overview

Page: 16-23

Abstract:In the western world, adjuvant systemic therapy together with widespread use of screening has led to a consistent decrease in breast cancer mortality since the nineties. This review article summarises… Read More »

Stability of Hospira filgrastim following changes to thermal and photic storage conditions

Page: 19-25

Study objectives: Protein-based medicines have specific storage requirements to ensure chemical stability and purity, but exposure to different environmental conditions can occur in normal use. The effect of extended unrefrigerated… Read More »

Food interactions and oral anticancer therapy

Page: 19-27

Abstract:Oral delivery for anticancer drugs is an attractive option, especially for palliative treatment. As this approach becomes more widely used, however, it is imperative to consider interactions that do not… Read More »

Treatment of metastatic breast cancer: an overview

Author(s): , ,
Page: 15-18

Abstract:Important progress has been achieved in the field of metastatic breast cancer (MBC) in the last decade. The integration of targeted agents either with endocrine or chemotherapy currently represents the… Read More »

New drugs—how much are they worth: the Italian experience

Page: 17-25

Abstract:The financing and delivery of health care in Italy, including current schemes to limit the growth in pharmaceutical expenditure, are discussed. Of particular focus is the Onco-AIFA (Agenzia Italiana del… Read More »

Go Back Print
Webdesign by I2CT